HCAR2
| Official symbol: | HCAR2 |
| Full name: | hydroxycarboxylic acid receptor 2 |
| Location: | 12q24.31 |
| Also known as: | HCA2, GPR109A, PUMAG, Puma-g, HM74A, NIACR1 |
| Entrez ID: | 338442 |
| Ensembl ID: | ENSG00000182782 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | G protein-coupled receptor |
| JensenLab PubMed score: | 125.99 (Percentile rank: 75.83%) |
| PubTator score: | 98.90 (Percentile rank: 77.52%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
